These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1059 related items for PubMed ID: 28828589

  • 21. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [18F]FDG PET/CT parameters.
    Dongxiang W, Liting L, Yujing L, Meijuan L, Shanshan G, Longbin X, Yanzhou C, Meiling C, Kang N, Haiqiang M, Linquan T, Qiuyan C.
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [Abstract] [Full Text] [Related]

  • 22. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC, Oechsle K, Kollmannsberger C, Dohmen BM, Bokemeyer C, Bares R, Vontheim R, Claussen CD.
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [Abstract] [Full Text] [Related]

  • 23. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.
    Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M.
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
    Chung HH, Cheon GJ, Kim JW, Park NH, Song YS.
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510
    [Abstract] [Full Text] [Related]

  • 25. Prognostic role of baseline 18 F-FDG PET/CT parameters in MALT lymphoma.
    Albano D, Bosio G, Camoni L, Farina M, Re A, Tucci A, Giubbini R, Bertagna F.
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic Value of Baseline 18F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study.
    Moon SH, Choi WH, Yoo IR, Lee SJ, Paeng JC, Jeong SY, Lee SW, Kim K, Choi JY.
    Korean J Radiol; 2018 Feb; 19(3):481-488. PubMed ID: 29713226
    [Abstract] [Full Text] [Related]

  • 28. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
    Dai N, Liu H, Deng S, Sang S, Wu Y.
    Technol Cancer Res Treat; 2021 Feb; 20():15330338211056478. PubMed ID: 34806464
    [Abstract] [Full Text] [Related]

  • 29. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma.
    Lim CH, Moon SH, Cho YS, Choi JY, Lee KH, Hyun SH.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1705-1712. PubMed ID: 31049603
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y, Wang L, Jiang X, She W, He L, Hu G.
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [Abstract] [Full Text] [Related]

  • 32. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 33. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
    Shin DY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):165-75. PubMed ID: 20872146
    [Abstract] [Full Text] [Related]

  • 34. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W, Zhao J, Wang C, Wang T, Xing Y.
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [Abstract] [Full Text] [Related]

  • 35. FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI.
    Stojiljkovic M, Sobic Saranovic D, Odalovic S, Popovic M, Petrovic J, Rankovic N, Veljkovic M, Artiko V.
    Radiol Oncol; 2022 Dec 01; 56(4):453-460. PubMed ID: 36317553
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D.
    Clin Transl Oncol; 2017 Nov 01; 19(11):1337-1349. PubMed ID: 28540535
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 01; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 38. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
    Maharjan S, Sharma P, Patel CD, Sharma DN, Dhull VS, Jain SK, Thulkar S, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Aug 01; 34(8):741-8. PubMed ID: 23676840
    [Abstract] [Full Text] [Related]

  • 39. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment 18F-FDG PET/CT of Primary Lesions for Pediatric Patients with Neuroblastoma.
    Wang G, Si Y, Liu J, Wang W, Yang J.
    Acad Radiol; 2024 Mar 01; 31(3):1091-1101. PubMed ID: 37748956
    [Abstract] [Full Text] [Related]

  • 40. The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.
    Kandemir O, Demir F, Avcı GG.
    Niger J Clin Pract; 2024 Jun 01; 27(6):748-753. PubMed ID: 38943299
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.